Question 1

What is Tarsus Pharmaceuticals, Inc.'s deferred tax assets and other non-current assets?

Accepted Answer

Tarsus Pharmaceuticals, Inc. (TARS) reported deferred tax assets and other non-current assets of $660K in Q2 2026.

Question 2

How has Tarsus Pharmaceuticals, Inc.'s deferred tax assets and other non-current assets changed year-over-year?

Accepted Answer

Tarsus Pharmaceuticals, Inc.'s deferred tax assets and other non-current assets decreased by 45.6% year-over-year, from $1.21M to $660K.

Question 3

What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s deferred tax assets and other non-current assets?

Accepted Answer

Over 5 years (2020 to 2025), Tarsus Pharmaceuticals, Inc.'s deferred tax assets and other non-current assets has grown at a -20.4% compound annual growth rate (CAGR), from $389K to $124K.

Question 4

What does deferred tax assets and other non-current assets mean?

Accepted Answer

Combined balance of non-current deferred tax assets and other miscellaneous non-current assets.

Line item	June 30, 2026	December 31, 2025
Intangible assets, net	6,885	7,366
Operating lease right-of-use assets	9,911	10,080
Long-term investments	6,682	3,870
Other assets	660	1,861
Total assets	$611,142	$562,158
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable	$40,141	$16,387

Deferred Tax Assets and Other Non-Current Assets at other companies

Other financials

Income statement

Balance sheet

Cash flow

Valuation

Profitability

Returns & leverage

Where this comes from

FAQ

Ask your AI about Tarsus Pharmaceuticals, Inc.'s deferred tax assets and other non-current assets.

Tarsus Pharmaceuticals, Inc. TARS Deferred Tax Assets and Other Non-Current Assets